Cantor Fitzgerald Starts Galena Biopharma (GALE) at Buy; New Approach to Breast Cancer
Tweet Send to a Friend
Cantor Fitzgerald initiates coverage on Galena Biopharma (NASDAQ: GALE) with a Buy. PT $4.00.
Analyst, Mara Goldstein, said, "alena ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Mara Goldstein, said, "alena ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
